Free Drug Concentration

Free Drug Concentration refers to the unbound fraction of a drug in plasma or tissues that is pharmacologically active and able to interact with biological targets. Many drugs bind to plasma proteins such as albumin or alpha-1 acid glycoprotein, reducing the free fraction available for therapeutic activity. Free concentration often correlates more directly with pharmacodynamic effects than total concentration, particularly for highly protein-bound compounds.

The pharmaceutical industry considers free drug concentration in pharmacokinetic modelling, dose selection, and drug-drug interaction assessment. Changes in protein binding can alter free concentrations without changing total levels, potentially impacting efficacy or toxicity. Special populations including critically ill patients may exhibit altered protein levels affecting binding and exposure. Bioanalytical methods measure free fractions using equilibrium dialysis or ultrafiltration techniques. Regulatory submissions may include free concentration data supporting exposure-response relationships and safety margins. As precision dosing expands, understanding free drug exposure becomes increasingly important for optimising therapeutic outcomes.